Open access · CC BY-NC 4.0
Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention
Cardiovascular Prevention and Pharmacotherapy · 2019
DOI: 10.36011/cpp.2019.1.e1 ↗At a glance
Journal article in Cardiovascular Prevention and Pharmacotherapy, 2019. Written by Jang-Whan Bae. Cited 1 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Není k dispozici žádný abstrakt.
Cite
APA
Bae, J. (2019). Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. https://doi.org/10.36011/cpp.2019.1.e1
Vancouver
Bae J. Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. 2019. doi:10.36011/cpp.2019.1.e1
BibTeX
@article{Bae2019,
author = {Bae, Jang-Whan},
title = {Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention},
journal = {Cardiovascular Prevention and Pharmacotherapy},
year = {2019},
doi = {10.36011/cpp.2019.1.e1}
}
EUVIMED